Carlotta Milocchi

Dr. Carlotta Milocchi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CMCarlotta Milocchi
Carlotta Milocchi
SNSilvia Nogara
Silvia Nogara
GMGiorgia Mazzuca
Giorgia Mazzuca
FRFederica Runfola
Federica Runfola
MCMartina Ciarcià
Martina Ciarcià
BFBenjamim Ficial
Benjamim Ficial
We aimed to evaluate the accuracy and reproducibility of right ventricular output (RVO) using different anatomical landmarks: the internal pulmonary valve diameter (PVD) between the valve hinge points (hinge-PVD) according to the traditional technique, and PVD between the valve leaflet tips (tip-PVD). This was a retrospective analysis of prospective collected data. All neonates with echocardiographic measurements of RVO and left ventricular output (LVO) without congenital heart disease, including patent ductus arteriosus and patent foramen ovale > 3 mm, were included. Accuracy was assessed by comparison with LVO. Intra- and inter-observer reproducibility of the off-line analysis were assessed. Forty-five neonates were included. RVO calculation with tip-PVD was more accurate than hinge-PVD in comparison with LVO, r2 0.712 versus 0.464, bias (95% limits of agreement) 1.4 mL/kg/min (−26–29 mL/kg/min) versus 61 mL/kg/min (−11–132 mL/kg/min), respectively. Both hinge-PVD and tip-PVD presented similar reproducibility, with an intra-observer bias (95% LOA) of 0.3 (−1.0–0.5) and –0.2 (−0.8–0.5) respectively, and an inter-observer bias of 0.1 (−1.3–1.6) and 0.1 (−1.4–1.6). RVO calculation using tip-PVD was more accurate than the conventional technique, with similar reproducibility.

11 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MBMariachiara Bosco
Mariachiara Bosco
Simone GarzonSimone Garzon
Simone Garzon
CSChiara Simonetto
Chiara Simonetto
BCBeatrice Cattin
Beatrice Cattin
EEElisa Ida Erbogasto
Elisa Ida Erbogasto
SUStefano Uccella
Stefano Uccella
Background and Objectives: Intrapartum clinical chorioamnionitis at term is a complication associated with adverse maternal and neonatal outcomes. We aimed to identify factors independently associated with severe histological chorioamnionitis in women with clinical chorioamnionitis at term and with severe histological chorioamnionitis accompanied by neonatal intensive care unit (NICU) admission, considered the most severe end of the spectrum. Materials and Methods: We retrospectively identified all women with a diagnosis of clinical chorioamnionitis during labor at term between 2017 and 2022. Maternal characteristics and maternal and neonatal outcomes were extracted from medical records. The study population was stratified by the presence or absence of histological chorioamnionitis. Results: Out of 12,332 women, 171 (1.4%) singleton pregnant women had an intrapartum diagnosis of clinical chorioamnionitis at term. A total of 96 (56.1%) were confirmed with severe histological chorioamnionitis. Thick meconium-stained amniotic fluid (MSAF) (OR = 5.88; 95% CI 1.12–30.86, p = 0.035) and advanced maternal age (OR = 1.14, 95% CI 1.01–1.29, p = 0.024) were independently associated with severe histologic chorioamnionitis. In women with severe acute histological chorioamnionitis, we observed a higher prevalence of neonatal NICU admission and longer NICU stay. Factors independently associated with severe histologic chorioamnionitis accompanied by adverse neonatal course (NICU admission) were maternal age, fetal tachycardia and thick meconium-stained amniotic fluid. Conclusions: The diagnosis of clinical chorioamnionitis has a low positive predictive value for intra-amniotic infection or inflammation. Factors such as maternal age, thick meconium-stained amniotic fluid and fetal tachycardia may help identify patients with underlying intra-amniotic infection and those at risk of worse perinatal outcomes. Improved identification may help avoid both over- and undertreatment and guide interventions aimed at preventing adverse neonatal outcomes.